We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISRG icon
26
Intuitive Surgical
ISRG
$127B
$278M 0.51%
774,195
+742,260
+2,324% +$255M
STE icon
27
Steris
STE
$22.3B
$277M 0.51%
1,139,449
+1,121,711
+6,324% +$256M
BSX icon
28
Boston Scientific
BSX
$69.5B
$270M 0.5%
6,357,680
+5,411,822
+572% +$227M
TSLA icon
29
Tesla
TSLA
$1.23T
$262M 0.48%
744,885
+680,721
+1,061% +$228M
BIO icon
30
Bio-Rad Laboratories Class A
BIO
$8.71B
$252M 0.47%
333,370
-105,974
-24% -$79.3M
JPM icon
31
JPMorgan Chase
JPM
$935B
$242M 0.45%
1,530,754
+1,435,816
+1,512% +$236M
SKX
32
DELISTED
Skechers
SKX
$237M 0.44%
5,450,266
+2,994,421
+122% +$134M
ELV icon
33
Elevance Health
ELV
$81.5B
$226M 0.42%
486,857
+425,351
+692% +$179M
LW icon
34
Lamb Weston
LW
$7.22B
$225M 0.42%
3,551,015
+3,105,026
+696% +$179M
TFX icon
35
Teleflex
TFX
$6.05B
$218M 0.4%
664,890
-24,019
-3% -$8.17M
SGEN
36
DELISTED
Seagen Inc. Common Stock
SGEN
$216M 0.4%
1,397,503
+440,891
+46% +$73.8M
T icon
37
AT&T
T
$159B
$205M 0.38%
11,051,812
+7,689,248
+229% +$144M
AMP icon
38
Ameriprise Financial
AMP
$48.3B
$205M 0.38%
679,926
+613,070
+917% +$181M
ICLR icon
39
Icon
ICLR
$12.6B
$192M 0.35%
619,530
+617,927
+38,548% +$173M
CFG icon
40
Citizens Financial Group
CFG
$30.3B
$183M 0.34%
3,879,285
+3,666,412
+1,722% +$177M
IBM icon
41
IBM
IBM
$211B
$181M 0.33%
1,356,328
+947,520
+232% +$119M
ABNB icon
42
Airbnb
ABNB
$89.9B
$179M 0.33%
1,073,555
-323,493
-23% -$57M
HZNP
43
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$179M 0.33%
1,656,679
+1,614,010
+3,783% +$176M
ABT icon
44
Abbott
ABT
$183B
$176M 0.33%
1,250,785
+1,005,234
+409% +$129M
GLOB icon
45
Globant
GLOB
$1.58B
$175M 0.32%
556,277
+357,877
+180% +$106M
GLD icon
46
PUT
SPDR Gold Trust
GLD
$131B
$172M 0.32%
1,007,500
-74,900
-7% -$12.6M
CRL icon
47
Charles River Laboratories
CRL
$11.2B
$171M 0.32%
454,795
+152,258
+50% +$59.2M
NTRA icon
48
Natera
NTRA
$38.3B
$170M 0.31%
1,815,919
+456,158
+34% +$47.3M
WFC icon
49
Wells Fargo
WFC
$261B
$168M 0.31%
3,510,561
+2,813,096
+403% +$138M
CVNA icon
50
Carvana
CVNA
$68.6B
$166M 0.31%
3,589,120
+2,894,500
+417% +$159M

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.